Related references
Note: Only part of the references are listed.High Low-Density Lipoprotein Cholesterol Inversely Relates to Dementia in Community-Dwelling Older Adults: The Shanghai Aging Study
Fen Zhou et al.
FRONTIERS IN NEUROLOGY (2018)
Blood cholesterol in late-life and cognitive decline: a longitudinal study of the Chinese elderly
Chaoran Ma et al.
MOLECULAR NEURODEGENERATION (2017)
Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study
Sabrina Schilling et al.
PLOS MEDICINE (2017)
Nonlinear Associations Between Plasma Cholesterol Levels and Neuropsychological Function
Carrington R. Wendell et al.
NEUROPSYCHOLOGY (2016)
Prevalence of mild cognitive impairment in an urban community in China: A cross-sectional analysis of the Shanghai Aging Study
Ding Ding et al.
ALZHEIMERS & DEMENTIA (2015)
The Shanghai Aging Study: Study Design, Baseline Characteristics, and Prevalence of Dementia
Ding Ding et al.
NEUROEPIDEMIOLOGY (2014)
Associations Between Serum Cholesterol Levels and Cerebral Amyloidosis
Bruce Reed et al.
JAMA NEUROLOGY (2014)
Smoking, hypercholesterolaemia and hypertension as risk factors for cognitive impairment in older adults
Olaoluwa Okusaga et al.
AGE AND AGEING (2013)
Midlife Vascular Risk Factors and Alzheimer's Disease: Evidence from Epidemiological Studies
Anna-Maija Tolppanen et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Development of Vascular Risk Factors over 15 Years in Relation to Cognition: The Hoorn Study
Yael D. Reijmer et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2012)
Serum ceramides increase the risk of Alzheimer disease The Women's Health and Aging Study II
Michelle M. Mielke et al.
NEUROLOGY (2012)
Impact of cardiovascular risk factors on cognitive function: The Troms⊘ study
K. A. Arntzen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Metabolic Syndrome and Risk of Dementia in Older Adults
Paola Forti et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2010)
The 32-year relationship between cholesterol and dementia from midlife to late life
M. M. Mielke et al.
NEUROLOGY (2010)
Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study
M. D. M. Haag et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Serum cholesterol changes after midlife and late-life cognition -: Twenty-one-year follow-up study
A. Solomon et al.
NEUROLOGY (2007)
Twenty-six-year change in total cholesterol levels and incident dementia - The Honolulu-Asia Aging Study
Robert Stewart et al.
ARCHIVES OF NEUROLOGY (2007)
Can statin therapy really reduce the risk of Alzheimer's disease and slow its progression?
T Miida et al.
CURRENT OPINION IN LIPIDOLOGY (2005)
Serum cholesterol and risk of Alzheimer disease - A community-based cohort study
G Li et al.
NEUROLOGY (2005)
High total cholesterol levels in late life associated with a reduced risk of dementia
MM Mielke et al.
NEUROLOGY (2005)
Cholesterol metabolism in the central nervous system during early development and in the mature animal
JM Dietschy et al.
JOURNAL OF LIPID RESEARCH (2004)
Relation of plasma lipids to Alzheimer disease and vascular dementia
C Reitz et al.
ARCHIVES OF NEUROLOGY (2004)
Plasma total cholesterol level as a risk factor for Alzheimer disease - The Framingham study
ZS Tan et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Apolipoprotein E ε4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease
M Kivipelto et al.
ANNALS OF INTERNAL MEDICINE (2002)
CNS synaptogenesis promoted by glia-derived cholesterol
DH Mauch et al.
SCIENCE (2001)
Midlife vascular risk factors and Alzheimer's disease in later life:: longitudinal, population based study
M Kivipelto et al.
BMJ-BRITISH MEDICAL JOURNAL (2001)
Share Paper
